Societal CDMO Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
220
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
12
- Investments
-
3
Societal CDMO General Information
Description
Societal CDMO Inc is a bi-coastal contract development and manufacturing organization. It offers capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules. They have an expertise in solving complex manufacturing problems, the Company provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.
Contact Information
Website
www.societalcdmo.com(Operating Subsidiary)
Corporate Office
- 1 East Uwchlan Avenue
- Suite 112
- Exton, PA 19341
- United States
Corporate Office
- 1 East Uwchlan Avenue
- Suite 112
- Exton, PA 19341
- United States
Societal CDMO Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Societal CDMO Comparisons
Industry
Financing
Details
Societal CDMO Competitors (22)
One of Societal CDMO’s 22 competitors is CordenPharma, a Private Equity-Backed company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CordenPharma | Private Equity-Backed | Basel, Switzerland | ||||
| Lonza Group | Corporation | Basel, Switzerland | ||||
| ThermoGenesis Holdings | Corporation | Rancho Cordova, CA | ||||
| Patheon | Formerly PE-Backed | Waltham, MA | ||||
| Amneal Pharmaceuticals | Formerly PE-Backed | Bridgewater, NJ |
Societal CDMO Patents
Societal CDMO Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190275054-A1 | Methods of administering intravenous meloxicam in a bolus dose | Active | 08-Mar-2018 | ||
| WO-2019173715-A1 | Methods of administering intravenous meloxicam in a bolus dose | Inactive | 08-Mar-2018 | ||
| JP-2015513309-A | Intranasal dexmedetomidine composition and method of use thereof | Active | 11-Dec-2011 | ||
| JP-2018030850-A | Intranasal dexmedetomidine composition and method of use thereof | Active | 11-Dec-2011 | ||
| EP-2787970-A2 | Intranasal dexmedetomidine compositions and methods of use thereof | Active | 11-Dec-2011 | A61K31/4174 |
Societal CDMO Signals
Societal CDMO Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Societal CDMO Investments & Acquisitions (3)
Societal CDMO’s most recent deal was a Merger/Acquisition with IriSys (Pharmaceuticals) for . The deal was made on 13-Aug-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| IriSys (Pharmaceuticals) | 13-Aug-2021 | Merger/Acquisition | Pharmaceuticals | ||
| Cornell University (Portfolio of neuromuscular blocking drugs) | 01-Jun-2017 | Corporate Asset Purchase | Buildings and Property | ||
| Alkermes (Manufacturing Faclity and Global Rights) | 13-Apr-2015 | Corporate Asset Purchase | Buildings and Property |
Societal CDMO FAQs
-
When was Societal CDMO founded?
Societal CDMO was founded in 2007.
-
Where is Societal CDMO headquartered?
Societal CDMO is headquartered in Exton, PA.
-
What is the size of Societal CDMO?
Societal CDMO has 220 total employees.
-
What industry is Societal CDMO in?
Societal CDMO’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Societal CDMO a private or public company?
Societal CDMO is a Private company.
-
What is the current valuation of Societal CDMO?
The current valuation of Societal CDMO is .
-
What is Societal CDMO’s current revenue?
The current revenue for Societal CDMO is .
-
How much funding has Societal CDMO raised over time?
Societal CDMO has raised $215M.
-
Who are Societal CDMO’s investors?
ALSO Holding, Athyrium Capital Management, Broadfin Capital, Cormorant Asset Management, and OrbiMed are 5 of 7 investors who have invested in Societal CDMO.
-
Who are Societal CDMO’s competitors?
CordenPharma, Lonza Group, ThermoGenesis Holdings, Patheon, and Amneal Pharmaceuticals are some of the 22 competitors of Societal CDMO.
-
When was Societal CDMO acquired?
Societal CDMO was acquired on 28-Feb-2024.
-
Who acquired Societal CDMO?
Societal CDMO was acquired by Bend Bioscience (Formerly CoreRx).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process